ChinaBio Today -- Lijun International Pharmaceutical agreed to set up a Joint Venture with Tonghua Dongbao Pharmaceuticals in Jilin Province. The JV will manufacture and sell large volume intravenous infusion solutions. Lijun is headquartered in Hong Kong, though the majority of its operations are in the PRC. More details....
Stock Symbols: (HKEX: 02005) (SHEX: 600867)
Richard Daverman, Editor